Evotec SE 2022 SR
The report highlights Evotec's commitment to drug discovery and sustainability, focusing on its mission to find cures for uncured diseases. In 2022, the company submitted near-term science-based targets to the SBTi, aiming for net-zero emissions by 2050. Key achievements include reaching a 31.4% share of women in senior management and maintaining high customer retention. The company also integrated two new sites and strengthened its ESG governance with a dedicated Supervisory Board committee. Despite a cyber-attack in early 2023, Evotec continues to prioritize resilience and its #researchneverstops ambition.
Company: Evotec SE
Sector: Manufacturing
Country: Germany
Year: 2022
Type: SR
Pages: 62
Back to company
Evotec SE
Sustainability Report
The report highlights Evotec's commitment to drug discovery and sustainability, focusing on its mission to find cures for uncured diseases. In 2022, the company submitted near-term science-based targets to the SBTi, aiming for net-zero emissions by 2050. Key achievements include reaching a 31.4% share of women in senior management and maintaining high customer retention. The company also integrated two new sites and strengthened its ESG governance with a dedicated Supervisory Board committee. Despite a cyber-attack in early 2023, Evotec continues to prioritize resilience and its #researchneverstops ambition.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2022
Reporting Period
Jan 1, 2022 - Dec 31, 2022
Fiscal Year
2022
Published
May 16, 2023
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
Sustainable Development Goals
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Women in Management
Net Zero Target
Employees